title: Half-life of the duck hepatitis B virus covalently closed circular DNA pool in vivo following inhibition of viral replication.
abstract: Covalently closed circular DNA (cccDNA) is a crucial intermediate in the replication of hepadnaviruses. We inhibited the replication of duck hepatitis B virus in congenitally infected ducks with a combination of lamivudine and a dideoxyguanosine prodrug. Inhibition of viral replication should prevent renewal of the cccDNA pool, and its decay was measured in liver biopsy samples collected over a 5-month period. In three ducks, the cccDNA pools declined exponentially, with half-lives ranging from 35 to 57 days. In two others, the pools declined exponentially for about 70 days but then stabilized at about 6 copies/diploid genome. The selection of drug-resistant virus mutants is an unlikely explanation for this unexpected stabilization of cccDNA levels. Liver sections stained for the cell division marker PCNA showed that animals in which cccDNA loss was continuous had significantly greater numbers of PCNA-positive nuclei than did those animals in which cccDNA levels had plateaued.
authors.affiliation: Department of Medical Microbiology and Immunology and Glaxo Wellcome Research Centre, University of Alberta, Edmonton, Alberta, Canada. bill.addison@ualberta.ca
authors.forename: William R
authors.initials: WR
authors.lastname: Addison
authors.forename: Kathie-Anne
authors.initials: KA
authors.lastname: Walters
authors.forename: Winnie W S
authors.initials: WW
authors.lastname: Wong
authors.forename: John S
authors.initials: JS
authors.lastname: Wilson
authors.forename: Danuta
authors.initials: D
authors.lastname: Madej
authors.forename: Lawrence D
authors.initials: LD
authors.lastname: Jewell
authors.forename: D Lorne J
authors.initials: DL
authors.lastname: Tyrrell
mesh_terms: D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology; D001086:Arabinofuranosyluracil / Q000031:analogs & derivatives / Q000494:pharmacology; D004270:DNA, Circular / Q000502:physiology*; D004279:DNA, Viral / Q000502:physiology*; D004372:Ducks; D005260:Female; D006207:Half-Life; D018347:Hepadnaviridae Infections / Q000821:virology; D015611:Hepatitis B Virus, Duck / Q000187:drug effects / Q000235:genetics / Q000502:physiology*; D006524:Hepatitis, Viral, Animal / Q000821:virology*; D008099:Liver / Q000821:virology; D008297:Male; D008969:Molecular Sequence Data; D014779:Virus Replication / Q000187:drug effects*
chemical_list: D000998:Antiviral Agents; D004270:DNA, Circular; D004279:DNA, Viral; D001086:Arabinofuranosyluracil; C034935:clevudine